(Q52726208)

6 May 2018

title

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. (English)

1 reference

6 May 2018

1 reference

1 reference

1 reference

1 reference

rotavirus VP6

15 October 2023

1

1 reference

6 May 2018

Suvi Lappalainen

object named as

Suvi Lappalainen

2

0 references

author name string

Kirsi Nurminen

3

1 reference

6 May 2018

Leena Huhti

4

1 reference

6 May 2018

Timo Vesikari

5

1 reference

6 May 2018

language of work or name

English

0 references

publication date

18 August 2011

1 reference

6 May 2018

published in

Vaccine

1 reference

6 May 2018

volume

29

1 reference

6 May 2018

issue

45

1 reference

6 May 2018

page(s)

8126-8133

1 reference

6 May 2018

Norovirus gastroenteritis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Systematic literature review of role of noroviruses in sporadic gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Differences in clinical presentation between norovirus genotypes in nursing homes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

The influence of antigen organization on B cell responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Global Illness and Deaths Caused by Rotavirus Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Immunity and correlates of protection for rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Rotavirus vaccines: recent developments and future considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Structural polymorphism of the major capsid protein of rotavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Functional mapping of protective domains and epitopes in the rotavirus VP6 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Intussusception among infants given an oral rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Molecular epidemiology of caliciviruses causing outbreaks and sporadic cases of acute gastroenteritis in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Prevalence of norovirus GII-4 antibodies in Finnish children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Norovirus P particle, a novel platform for vaccine development and antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Characterization of the homo- and heterotypic immune responses after natural norovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Serological correlate of protection against norovirus-induced gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Noroviruses in children seen in a hospital for acute gastroenteritis in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

More on RotaShield and intussusception: the role of age at the time of vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.08.026

1 reference

6 May 2018

PubMed ID

21854823

1 reference

6 May 2018